犹他医疗产品公司和FDA:监管教条与灵活解释

Quality Assurance Journal Pub Date : 2006-06-01 DOI:10.1002/QAJ.371

C. Burgess, R. Mcdowall

{"title":"犹他医疗产品公司和FDA:监管教条与灵活解释","authors":"C. Burgess, R. Mcdowall","doi":"10.1002/QAJ.371","DOIUrl":null,"url":null,"abstract":"This paper reviews the regulatory compliance background and the 2005 court case between the Food and Drug Administration (FDA) and Utah Medical Products Incorporated which supported the company's and not the Agency's interpretation of 21 Code of Federal Regulations (CFR) Part 820, the Quality System Regulations (QSR). This is the first time that the Agency has lost such a court case; the key issues in the case are presented and discussed. The judgement also shows the value of re-reading the regulations to interpret what is actually required rather than custom and practice. Copyright © 2006 John Wiley & Sons, Ltd.","PeriodicalId":147931,"journal":{"name":"Quality Assurance Journal","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Utah Medical Products Inc. and the FDA: Regulatory Dogma versus Flexible Interpretation\",\"authors\":\"C. Burgess, R. Mcdowall\",\"doi\":\"10.1002/QAJ.371\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This paper reviews the regulatory compliance background and the 2005 court case between the Food and Drug Administration (FDA) and Utah Medical Products Incorporated which supported the company's and not the Agency's interpretation of 21 Code of Federal Regulations (CFR) Part 820, the Quality System Regulations (QSR). This is the first time that the Agency has lost such a court case; the key issues in the case are presented and discussed. The judgement also shows the value of re-reading the regulations to interpret what is actually required rather than custom and practice. Copyright © 2006 John Wiley & Sons, Ltd.\",\"PeriodicalId\":147931,\"journal\":{\"name\":\"Quality Assurance Journal\",\"volume\":\"41 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Quality Assurance Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/QAJ.371\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quality Assurance Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/QAJ.371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Utah Medical Products Inc. and the FDA: Regulatory Dogma versus Flexible Interpretation

This paper reviews the regulatory compliance background and the 2005 court case between the Food and Drug Administration (FDA) and Utah Medical Products Incorporated which supported the company's and not the Agency's interpretation of 21 Code of Federal Regulations (CFR) Part 820, the Quality System Regulations (QSR). This is the first time that the Agency has lost such a court case; the key issues in the case are presented and discussed. The judgement also shows the value of re-reading the regulations to interpret what is actually required rather than custom and practice. Copyright © 2006 John Wiley & Sons, Ltd.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Quality Assurance Journal

自引率

0.00%

发文量